Il nostro contributo

L’impatto scientifico misura l’influenza e la rilevanza delle scoperte e delle pubblicazioni di un istituto di ricerca. Per IFOM, l’impatto scientifico non si limita solo alla quantità di pubblicazioni, ma si estende alla qualità delle riviste su cui vengono pubblicati i nostri studi, alla visibilità dei nostri risultati e alla capacità di trasformare queste scoperte in avanzamenti concreti nella lotta contro il cancro.

Tirtei E, Difilippo V, Divincenzo F, Asaftei SD, Ratto N, Piana R, Pellegrino P, Linari A, Papotti M, Mareschi K, Parlato C, Guarrera S, Minucci S, Rabusin M, Manzitti C, Prete A, Mercolini F, Luksch R, Meazza C, Parafioriti A, Tamburini A, Coccoli L, Mura R, Zecca M, Palmerini E, Ibrahim T, Peirone S, Penolazzi L, De Luna E, Cagnazzo C, Bombaci S, Ferrero I, Niclot AGSB, Proto CF, Spadea M, Quarello P, Marini E, Gizzi K, Fenoglio B, Livellara V, Di Gangi A, Puma N, Sironi G, Di Bernardo A, Cereda M, Fagioli F

Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Cancer Res Commun 2026; 857-872. doi: 10.1158/2767-9764.CRC-25-0697

Mazzoli G, Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Fotia G, De Monte M, Ligorio F, Jacobs F, Armani G, Zurlo C, Menichetti A, Griguolo G, Faso V, Schianca AC, Munzone E, Marra A, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2.

Breast 2026; 104692. doi: 10.1016/j.breast.2026.104692

Dauccia C, Bruzzone M, Arecco L, Blondeaux E, Sirico M, Gerosa R, Franzoi MA, Brandão M, Perrone L, Pedrazzoli P, Desmedt C, Di Cosimo S, Vernieri C, Collet L, Lambertini M, de Azambuja E, Agostinetto E

Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis.

Breast 2026; 104710. doi: 10.1016/j.breast.2026.104710

Marchesi S, Guidolin C, Massey AE, Lemahieu G, Lavagnino Z, Beznoussenko GV, Mironov AA, Green BJ, Allievi E, Martini E, Magni S, Ghisleni A, Lomazzi C, Benvenuto AF, Schertel A, van Faassen DA, Freddi S, Bertalot G, Parazzoli D, Maiuri P, Mapelli M, Pece S, Sigismund S, Gauthier NC, Cavalcanti-Adam EA, Cartagena-Rivera AX, Giavazzi F, Scita G, Disanza A

Mechanisms of active wetting and fluidification in epithelial cell collectives.

Nat Mater 2026; . doi: 10.1038/s41563-026-02553-2

Fusilier Z, Clément A, Simon F, Calvente I, Jean-Marie R, Mathieu M, Calmettes V, Piastra-Facon F, Quintana-Perez Y, Clement JG, Crestey L, Lumineau E, Henninger R, Tonani M, Manriquez V, Lacerda Mariano L, Bensaid L, de Villemagne P, Piaggio E, Semetey V, Coscoy S, Martini E, Scita G, Gelly JC, Ivaska J, Isambert H, Goudot C, Pierobon P, Lennon-Duménil AM, Moreau HD

Macrophages restrict tumor immune infiltration by controlling collagen topography.

Sci Immunol 2026; eadw8291. doi: 10.1126/sciimmunol.adw8291

Lonardi S, Cancila V, Morello G, Varano G, Balzarini P, Pellegrini V, Albertini E, Giampaolo S, Pietrini I, Thanasi H, Sindaco P, Piazza F, Manni S, Lorenzini D, Pruneri G, Dei Tos AP, Ponzoni M, Facchetti F, Pizzi M, Lorenzi L, Tripodo C, Casola S

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

Leukemia 2026; . doi: 10.1038/s41375-026-02896-4

Brevi A, Lorenzoni M, Caputo S, Yamada Y, Grioni M, Cogrossi LL, Martinez-Vidal L, Cassina V, Cipria D, Venegoni C, Zordan P, Matafora V, Tascini AS, Tenace NP, Campanile R, Cucchiara V, Pinna V, Jachetti E, Galli R, Bachi A, Colecchia M, Briganti A, Freschi M, Mantegazza F, Lombardo A, Demichelis F, Beltran H, Alfano M, Bellone M

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Cancer Res 2026; . doi: 10.1158/0008-5472.CAN-25-2704

Vinciguerra M, El Kharef C, Bruhn C, Falbo L, Milanese C, Audano M, Beznoussenko GV, Mironov AA, Delia D, Foiani M, Mastroberardino PG, Mitro N, Costanzo V

Targeting the FNIP2-SERCA2b axis improves metabolic and mitochondrial defects in Ataxia Telangiectasia.

Cell Death Dis 2026; . doi: 10.1038/s41419-026-08507-5

Martelli G, Barretta F, Muzi C, Listorti C, Pilotta F, Maugeri I, Osio C, Bonfili D, Vernieri C, Bianchi G, Pruneri G, Folli S, Scaperrotta G, Baili P, Miceli R, Ferraris C

Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study.

Ann Surg Oncol 2026; 2255-2266. doi: 10.1245/s10434-025-18673-z

Kaivola J, Punovuori K, Chastney MR, Abdo H, Follain G, Mathieu M, Joshi O, Miroshnikova YA, Krautgasser F, Di Franco J, Conway JRW, Held S, Bertillot F, Hagström J, Mäkitie A, Irjala H, Ventelä S, Hamidi H, Scita G, Cerbino R, Wickström SA, Ivaska J

Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties.

Nat Mater 2026; . doi: 10.1038/s41563-025-02473-7

Giuli MV, Mancusi A, Natiello B, Di Cristofano S, Reali R, Pignataro MG, D'Andrea D, Di Magno L, Nicoletti C, Giorgi A, Macone A, Camerini S, Casella M, Peruzzi G, Zema S, Canettieri G, Tomao F, Palaia I, Pernazza A, Rustighi A, Palermo R, Raimondo D, Monti A, Doti N, d'Amati G, Del Sal G, Screpanti I, Talora C, Bellavia D, Checquolo S

Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.

J Exp Clin Cancer Res 2026; . doi: 10.1186/s13046-026-03658-x

Avolio M, Leto SM, Sassi F, Lupo B, Grassi E, Catalano I, Zanella ER, Vurchio V, Cottino F, Tsantoulis PK, Lazzari L, Luraghi P, Ferri M, Galimi F, Berrino E, Bellomo SE, Viviani M, Sogari A, Mauri G, Tosi F, Cruciani F, Sartore-Bianchi A, Siena S, Borghi F, Torri V, Élez E, Tabernero J, Nieva M, Montagut C, Tarazona N, Cervantes A, Tejpar S, Bardelli A, Marchiò C, Marsoni S, Bertotti A, Trusolino L

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Cancer Discov 2026; 270-295. doi: 10.1158/2159-8290.CD-24-0556

Vittorelli N, Gómez-Muñoz C, Andriushchenko I, Ollivier L, Agier N, Delmas S, Corbeau Y, Achaz G, Cosentino Lagomarsino M, Liti G, Llorente B, Fischer G

Repeated losses of self-fertility shaped heterozygosity and polyploidy in yeast evolution.

Proc Natl Acad Sci U S A 2026; e2525679123. doi: 10.1073/pnas.2525679123

Laue K, Pozzi S, Zerbib J, Bertolio R, Eliezer Y, Cohen-Sharir Y, Winkler T, Caputo M, Ricci AA, Adler L, Khoury R, Longobardi G, Slutsky R, Leikin-Frenkel AI, Ovadia S, Lange K, Rustighi A, Piazza S, Sacconi A, Magesh RY, Keller FN, Berthelet J, Schäffer A, Saad R, Israeli Dangoor S, Szczepanowska K, Barshack I, Liao Y, Malitsky S, Brandis A, Broggini T, Czabanka M, Shi W, Merino D, Watson EV, Blandino G, Erez A, Ashery-Padan R, Medyouf H, Bertero L, Del Sal G, Satchi-Fainaro R, Ben-David U

p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.

Nat Genet 2026; 116-131. doi: 10.1038/s41588-025-02446-1

Makkieh M, Passeri AA, Lazzari D, Marchesi S, Disanza A, Salem RKA, Bonacci F, Mazzella C, Martini E, Tonani M, Donati L, Bellini E, Abdo H, Pineau J, Magni S, Orsenigo F, Piel M, Fioretto D, Martino S, Mattarelli M, Scita G, Green BJ, Caponi S

Brillouin Microscopy of Breast tumor Spheroids On-a-Chip: Mechanical and Transcriptional Responses to Microfluidic-Induced Rapid Deformations.

Adv Sci (Weinh) 2026; e13153. doi: 10.1002/advs.202513153

Abdo H, Barzaghi L, Shen Y, Bellini E, Martini E, Magni S, Barozzi S, Orsenigo F, Parazzoli D, Beznoussenko GV, Franco JD, Krautgasser F, Kaivola J, Cinquanta M, Lazzarin A, Sigismund S, Ivaska J, Cerbino R, Scita G

De Novo Gene Transcription of Connexin Mediates Cytoplasmic Fluid Exchange and Flocking Transitions in Physiological and Cancerous Epithelial Systems.

Adv Sci (Weinh) 2026; e08648. doi: 10.1002/advs.202508648

Masud W, Russo L, Chapdelaine-Trépanier V, Hayward SB, He W, Cirò M, Mercurio C, Xu H, Ciccia A, Cuella-Martin R, Leuzzi G

A base editing resource for functional annotation of DNA repair variants in breast-derived cell models.

Front Cell Dev Biol 2026; 1714494. doi: 10.3389/fcell.2026.1714494

Esposito F, Capozzo I, Riccardi A, Gioia U, Modafferi S, Manfredi L, Colantoni A, Tavella S, Cabrini M, Iannelli F, di Lillo A, d'Adda di Fagagna F, Francia S

DROSHA, DICER, and damage-induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break.

Cell Rep 2025; 116605. doi: 10.1016/j.celrep.2025.116605

Anfuso B, Velnati S, Selvestrel D, Garlant C, Ferracci E, Baj G, Parisse P, Overi D, Bertolio R, Bulla R, Sonzogni A, Bramuzzo M, Casalis L, Cocomello N, Baratta F, Del Ben M, Giraudi P, Tiribelli C, Rosso N, Mastronardi M, Tarchi P, Pinamonti M, Zanconati F, de Manzini N, Gaudio E, Palmisano S, Bonazza D, Del Sal G, Carpino G, Chiacchiera F, Sorrentino G

An organotypic model of ductular reaction reveals a mevalonate-dependent vulnerability in reactive biliary cells.

Cell Rep 2025; 116681. doi: 10.1016/j.celrep.2025.116681

Modafferi S, Farina S, Esposito F, Brandi O, Di Salvio M, Della Valle I, D'Uva S, Scarian E, Cicio G, Riccardi A, Pisati F, Garbelli A, Santini T, Pansarasa O, Morlando M, D'Ambrosi N, Cozzolino M, Cestra G, d'Adda di Fagagna F, Gioia U, Francia S

DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue.

Cell Death Differ 2025; 2309-2322. doi: 10.1038/s41418-025-01530-7

Amatu A, Patelli G, Zampino MG, Bergamo F, Mosconi S, Tosi F, Ciardiello D, Lonardi S, Negrini G, Sibio D, Gerardi MA, Galuppo S, Filippone FR, Carnevali P, Borin S, Pilati P, Poiasina E, Bonazzina E, Gervaso L, Mammano E, Bracco F, Bergamaschi L, Spolverato G, Origi M, Romario UF, Mauri G, Fazio N, Forti E, De Roberto G, Cristofori C, Burti C, Asmundo L, Funicelli L, Ramondo G, Bonaffini PA, Mariano S, Lazzari L, Ghezzi S, Isella C, Cantarella D, Aquilano MC, Bottiglieri L, Bonoldi E, Mutignani M, Torri V, Medico E, Bardelli A, Marsoni S, Vanzulli A, Palazzi MF, Ferrari GC, Bencardino K, Sartore-Bianchi A, Siena S

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Lancet Oncol 2025; 1612-1625. doi: 10.1016/S1470-2045(25)00542-X

Eli S, Rauso G, Ghezzi P, Szczerkowski JLA, Bruzzi M, Rizzelli F, Iommazzo F, Loffreda A, Castagna F, Donà F, Gaddoni C, Dondi A, Marenda M, Rodighiero S, Tournier P, Lavagnino Z, Parazzoli D, Gauthier NC, Tamburri S, Pasini D, Habib SJ, Mapelli M

Localized Wnt-signaling promotes asymmetric NuMA-dependent oriented divisions and unequal apportioning of mitochondria.

Nat Commun 2025; 10690. doi: 10.1038/s41467-025-65775-z

Lauriola A, Enriqué Steinberg JH, Sarubo M, Maspero E, Rossi FA, Mouri Y, Pedretti M, Hajisadeghian M, Taibi V, Vettori A, Vitulo N, Assfalg M, D'Onofrio M, Rossi M, Yasue A, Astegno A, Polo S, Santi S, Kudo Y, Guardavaccaro D

The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cells.

Mol Cell 2025; 4254-4267.e9. doi: 10.1016/j.molcel.2025.10.005

Sepe S, Rey F, Mancheno-Ferris A, Bigi A, Fani G, Damiani D, Cabrini M, Marinelli E, Aguado J, Contu L, di Lillo A, Boggio S, Tavella S, Rosso I, Gustincich S, Chiti F, d'Adda di Fagagna F

Telomeric DNA damage response mediates neurotoxicity of Aβ42 oligomers in Alzheimer's disease.

EMBO J 2025; 6078-6111. doi: 10.1038/s44318-025-00521-1

Buonaiuto R, Fordellone M, Caltavituro A, Cataldo ML, Criscitiello C, Dieci MV, Lambertini M, Botticelli A, Giuliano M, Giordano A, Mangiacotti F, Grieco A, Longobardi A, Caputo R, Pagliuca M, Vernieri C, Malorni L, Gerratana L, Arpino G, Chiodini P, De Laurentiis M, De Angelis C

Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.

EClinicalMedicine 2025; 103535. doi: 10.1016/j.eclinm.2025.103535

Ponzo M, Drufuca L, Buracchi C, Sindoni MM, Nucera S, Bugarin C, Bason R, Rossetti G, Bonnal R, Meli C, Rambaldi B, Lussana F, Ferrari S, Moretti A, Dastoli G, Risca G, Pellegrino C, Manz MG, Galimberti S, Rambaldi A, Gaipa G, Biondi A, Pagani M, Magnani CF

Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

J Immunother Cancer 2025; . doi: 10.1136/jitc-2025-011768

Rosti V, Lembo G, Petrini C, Gorini F, Quadri R, Cordiglieri C, Mutarelli M, Salviato E, Casari E, Di Patrizio Soldateschi E, Montanari E, Albo G, Ripa F, Fasciani A, Crosti M, De Lorenzis E, Maggioni M, Vaira V, Vivo M, Ferrari F, Lanzuolo C

Chromatin remodeling restrains oncogenic functions in prostate cancer.

Nat Commun 2025; 9174. doi: 10.1038/s41467-025-64213-4

Alaimo A, Carbone FG, Buzo K, Annesi N, Genovesi S, Lorenzato A, Widmann K, Libergoli M, Marmocchi E, Bertalot G, Brolese A, Papotti MG, Molinaro L, Caffo O, Barbareschi M, Bardelli A, Romanel A, Arena S, Lunardi A

TRPM8 levels determine tumor vulnerability to channel agonists.

Mol Oncol 2025; 2905-2920. doi: 10.1002/1878-0261.70049

Vanni G, Citron A, Suli A, Contessotto P, Caire R, Gandin A, Mantovan G, Zanconato F, Brusatin G, Di Palma M, Peirano E, Pozzer LS, Albanese C, Steiner RA, Cordenonsi M, Panciera T, Piccolo S

Microtubule architecture connects AMOT stability to YAP/TAZ mechanotransduction and Hippo signalling.

Nat Cell Biol 2025; 1725-1738. doi: 10.1038/s41556-025-01773-z

Zribi S, Giannitelli GJ, Bernardini L, Censi F, Camerini S, Bertuccini L, Iosi F, Giannella E, Sanchez M, Consoli E, Casagrande A, Cenci A, Floridia G, Novelli A, Giuliani A, Costanzo V, Crescenzi M, Pajalunga D

Structural obstruction to full DNA replication in terminally differentiated skeletal muscle cells.

EMBO Rep 2025; 4633-4655. doi: 10.1038/s44319-025-00554-x

Cancila V, Bertolazzi G, Chan AS, Medico G, Bastianello G, Morello G, Paysan D, Lai C, Hong L, Shenoy G, Jaynes PW, Schiavoni G, Mattei F, Piconese S, Revuelta MV, Noto F, Businaro L, De Ninno A, Cammarata I, Pagni F, Venkatachalapathy S, Sangaletti S, Di Napoli A, Cicio G, Vacca D, Lonardi S, Lorenzi L, Ferreri AJ, Belmonte B, Liu M, Lakshmanan M, Ong MS, Zhang B, See T, Lam KP, Varano G, Colombo MP, Bicciato S, Inghirami G, Cerchietti L, Ponzoni M, Zappasodi R, Metzger E, Beechem J, Facchetti F, Foiani M, Casola S, Jeyasekharan AD, Tripodo C

Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone.

J Clin Invest 2025; . doi: 10.1172/JCI187371

Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillère R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Blériot C, Liu P, Zhao L, Creusot L, Rolhion N, Derosa L, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C

Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.

Cancer Discov 2025; 1905-1926. doi: 10.1158/2159-8290.CD-24-1230

Vitiello PP, Valsecchi AA, Duregon E, Di Celle PF, Cassoni P, Papotti M, Bardelli A, Di Maio M

KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges.

Cancers (Basel) 2025; . doi: 10.3390/cancers17172803

Brunet L, Alexandre D, Lee J, Blanquer-Rosselló MDM, Bracquemond D, Guernet A, Chhouri H, Goupil M, Kherrouche Z, Arabo A, Mancini M, Cartier D, Yao S, Godefroy D, Dehedin J, Li JR, Duparc C, Jamme P, Vinchent A, Bérard C, Tulasne D, Arena S, Bardelli A, Cheng C, Cho BC, Wurtz O, Coulouarn C, Maraver A, Aaronson SA, Cortot AB, Anouar Y, Grumolato L

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Nat Commun 2025; 7853. doi: 10.1038/s41467-025-61788-w

Castagnoli L, Bonì F, Bigliardi M, Toneguzzo P, Corsetto PA, Galasso G, Franceschini A, Cocomazzi P, Regondi V, Capuzzoni C, Rizzo AM, Ligorio F, Vernieri C, Seneci P, Arosio D, Tagliabue E, Mastrangelo E, Milani M, Pupa SM

Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.

Sci Rep 2025; 28709. doi: 10.1038/s41598-025-14639-z

D'Oria C, Cincinelli G, Bason R, Pisati F, Simoncello F, Scotti I, Giudice L, Suardi I, Ferrua P, Fossati C, Randelli PS, Caporali R, Pagani M, Ingegnoli F

Patient-Derived Explants of Osteoarthritic Synovium as Ex Vivo Model for Preclinical Research.

Int J Mol Sci 2025; . doi: 10.3390/ijms26146665

Vaurs M, Claude E, Zanella E, Rodrigues J, Nassour J, Karlseder J, Azzalin CM, Doksani Y, Decottignies A

TRF1 relies on fork reversal to prevent fragility at human telomeres.

Nat Commun 2025; 6439. doi: 10.1038/s41467-025-61828-5

Marasco M, Kumar D, Garcia Borrego S, Seale T, Maddalena G, Mezzadra R, Belanger K, Cole S, Perez B, Luan W, Mukherjee R, Aricescu I, Markov V, Zhu Y, Arena S, Bardelli A, de Stanchina E, Lowe SW, Burkhart RA, Zimmerman JW, Yaeger R, Kopetz SE, Rosen N, Misale S

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Cancer Discov 2025; 1392-1409. doi: 10.1158/2159-8290.CD-24-0614

Varano G, Lonardi S, Sindaco P, Pietrini I, Morello G, Balzarini P, Vit F, Neuman H, Bertolazzi G, Brambillasca S, Parr NC, Chiarini M, Bellesi S, Maiolo E, Giampaolo S, Mainoldi F, Selvarasa V, Arima H, Pellegrini V, Pagani C, Bugatti M, Ranise C, Taddei TM, Sonoki T, Thanasi H, Morlacchi E, Segura-Garzon D, Albertini E, Daffini R, Sivacegaram A, Yang H, Li Y, Cancila V, Cicio G, Robusto M, Leuzzi B, Andronache A, Trifiro P, Riboni M, Minardi SP, Bonnal RJP, Gonzalez CL, Visco E, Capaccio P, Torretta S, Pignataro L, Almici C, Varasi M, Larocca LM, Siebert R, Falini B, Ferreri AJM, Tucci A, Lorenzini D, Cabras AD, Pruneri G, Di Napoli A, Ungari M, Pizzi M, Hohaus S, Mercurio C, Song JY, Chan WC, Lorenzi L, Bomben R, Ponzoni M, Mehr R, Tripodo C, Facchetti F, Casola S

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.

Blood Cancer Discov 2025; 364-393. doi: 10.1158/2643-3230.BCD-25-0099

Pizzi M, Lorenzi L, Scarmozzino F, Albertini E, Balzarini P, Sbaraglia M, Santoro L, Chiudinelli M, Mussolin L, Carraro E, Cutrone C, Casola S, Pellegrini V, Nalio S, Bonaldi L, Pillon M, Dei Tos AP

Reactive Bcl2-positive germinal centres in paediatric tonsils: expanding the spectrum of lymphoma mimickers in children and adolescents.

Histopathology 2025; 145-152. doi: 10.1111/his.15460

Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Miliziano D, Menichetti A, Ligorio F, Zurlo C, Griguolo G, Berton Giachetti PP, Faso V, Corti C, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.

Ann Oncol 2025; 762-774. doi: 10.1016/j.annonc.2025.03.023

%PLACEHOLDER%